Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,949 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Active, Not Recruiting

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

NCT05867303

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations
  • ICON Cancer Centre Wesley Auchenflower, Queensland, Australia
  • Southern Oncology Clinical Research Unit Bedford Park, South Australia, Australia
  • Cabrini Hospital Malvern Malvern, Victoria, Australia
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Active, Not Recruiting

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

NCT05013099

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Providence Saint John's Cancer Institute Santa Monica, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)

NCT02293980

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 25 locations
View Trial Details

Related conditions